Neuroone Medical Technologies (NMTC) Short-term Investments (2022 - 2023)
Neuroone Medical Technologies' (NMTC) quarterly Short-term Investments came in at $995432.0 in Q1 2023, down 66.54% on a QoQ basis from $3.0 million in Q4 2022.
Neuroone Medical Technologies (NMTC) Short-term Investments (2022 - 2023) Analysis & Trends
Neuroone Medical Technologies (NMTC) has 2 years of Short-term Investments data on file, last reported at $995432.0 in Q1 2023.
- Quarterly Short-term Investments changed N/A year-over-year to $995432.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $995432.0 (changed N/A YoY) and the FY2022 annual result came in at $3.0 million, changed N/A from the prior year.
- Short-term Investments slipped to $995432.0 in Q1 2023, from $3.0 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $3.0 million in Q3 2022 to a low of $995432.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Neuroone Medical Technologies | 17.95 Mn | 15.91 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 995,432.00 |
| Dec 31, 2022 | 2.98 Mn |
| Sep 30, 2022 | 2.98 Mn |